In a study published in Nature Cancer, the team showed that their compound binds to MCL1, removing its protective effects and triggering cell death in cancer. Importantly, unlike other MCL1 inhibitors ...
Nov. 11, 2024 — Researchers have discovered a new way in which RAS genes, which are commonly mutated in cancer, may drive tumor growth beyond their well-known role in signaling at the cell surface.